| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 12/24/2008 | WO2008155468A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155441A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155140A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | WO2008125867A3 Process for the preparation of gefitinib |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | WO2008033748A3 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 12/24/2008 | WO2008009078A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 12/24/2008 | WO2008009077A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 12/24/2008 | EP2004641A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 12/24/2008 | EP2004615A2 Quinazolines for pdk1 inhibition |
| 12/24/2008 | EP2004614A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 12/24/2008 | EP2004607A2 New compounds |
| 12/24/2008 | EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/24/2008 | EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
| 12/24/2008 | EP2004188A2 Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor |
| 12/24/2008 | DE102007028714A1 Ionische N-haltige Verbindungen Ionic compounds containing nitrogen |
| 12/24/2008 | CN101328138A Preparation of trimethoprim and intermediate |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100445270C Pyrimidine compounds |
| 12/24/2008 | CN100445269C 2-substituted pyrimidines |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CA2691227A1 Activators and therapeutic applications thereof |
| 12/24/2008 | CA2691100A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | CA2690436A1 Amine salts of a crth2 antagonist |
| 12/24/2008 | CA2690428A1 Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex |
| 12/24/2008 | CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 12/24/2008 | CA2690172A1 Particulates of a crth2 antagonist |
| 12/24/2008 | CA2689393A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | CA2687258A1 Arylamide pyrimidone derivatives |
| 12/24/2008 | CA2687255A1 Heteroarylamide pyrimidone derivatives |
| 12/24/2008 | CA2687151A1 Heteroarylamide pyrimidone compounds |
| 12/23/2008 | US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety |
| 12/23/2008 | US7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468243 2-aminopyrimidin-4-one nucleic acid labeling compounds |
| 12/23/2008 | US7468212 Organic electroluminescent device |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/18/2008 | WO2008152471A1 Quinazoline derivative useful as toll-like receptor antagonist |
| 12/18/2008 | WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase |
| 12/18/2008 | WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses |
| 12/18/2008 | WO2008151510A1 Preparation of 4-(fluorophenyl)-6-isopropyl-2-(n-methyl-n-methylsulfonylamino)- 5-formyl-pyrimidine |
| 12/18/2008 | WO2008118391A3 Triazinone and diazinone derivatives useful as hsp90 inhibitors |
| 12/18/2008 | WO2008117060A3 Co-crystals of cyprodinil and pyrimethanil |
| 12/18/2008 | WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases |
| 12/18/2008 | WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| 12/18/2008 | WO2008033764A3 Quinazolinone and isoquinolinone acetamide derivatives |
| 12/18/2008 | WO2008031888A3 Condensed pyrimidinones active on glutamatergic receptors |
| 12/18/2008 | US20080312449 New Compounds |
| 12/18/2008 | US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 12/18/2008 | US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders |
| 12/18/2008 | US20080312248 Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors |
| 12/18/2008 | US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 12/18/2008 | US20080312192 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases |
| 12/18/2008 | US20080312183 3-benzoyl-1-[(Z)-4-(trityloxy)-2-butenyl]-1,2,3,4-tetrahydro-2,4-pyrimidinedione; antiprotozoa agents; Deoxyuridine triphosphate nucleotidohydrolase inhibitors; malaria |
| 12/18/2008 | US20080312084 2-Fluoro-6-[(4,6-dimethoxytriazin-2-yl)carbonyl]-N-difluoromethanesulfonanilide; controlling paddy crop weeds; reacting 2-Chloro-6-[(4,6-dimethoxytriazin-2-yl)methyl]aniline with difluoromethanesulfonyl chloride; controlling weeds which express resistance against existing herbicides |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/18/2008 | US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents |
| 12/18/2008 | US20080308770 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors |
| 12/18/2008 | DE60132178T2 CRISTALLINSALZE VON 7-i4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL -(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE CRISTALLI SALTS OF 7-I4 (4-fluorophenyl) -6-isopropyl-2-iMETHYL (methylsulfonyl) PYRIMIDIN AMINO-5-YL - (3R, 5S) -3,5-dihydroxyhept-6-enoic acid |
| 12/18/2008 | CA2691987A1 Antibacterial agents |
| 12/18/2008 | CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2001853A1 Novel guanidine derivatives and their medical use |
| 12/17/2008 | EP2001488A2 Prevention and treatment of cancer and other diseases |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1198458B1 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 12/17/2008 | CN101326168A Prokineticin 1 receptor antagonists |
| 12/17/2008 | CN101323598A Preparation of 5,5-diethylmalonylurea |
| 12/17/2008 | CN101323597A Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde |
| 12/17/2008 | CN101323596A 2-site ethynyl contained pyrimidine ring liquid crystal compounds and method for preparing the same |
| 12/17/2008 | CN101323595A Synthetic method 1,2-dimethyl-1,4,5,6-tetrahydrochysene pyrimidine |
| 12/17/2008 | CN100443463C Substituted p-trifluoromethyl phenyl ether compound and its prepn and application |
| 12/16/2008 | US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease |
| 12/16/2008 | US7465740 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 12/16/2008 | US7465738 Gene for spinal muscular atrophy |
| 12/16/2008 | US7465735 crop protection agents for controlling harmful fungi; improved activity; 6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-trifluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber |
| 12/16/2008 | US7465734 Detecting potential therapeutic agent |
| 12/16/2008 | US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 12/16/2008 | US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus |
| 12/16/2008 | CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 12/16/2008 | CA2302937C Method for producing (hetero)aromatic hydroxylamines |
| 12/11/2008 | WO2008151183A1 Heterocyclic compounds and uses thereof |
| 12/11/2008 | WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 12/11/2008 | WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor |
| 12/11/2008 | WO2008148840A1 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 12/11/2008 | WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 12/11/2008 | WO2008021891A3 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 12/11/2008 | WO2008016522A3 Hiv reverse transcriptase inhibitors |
| 12/11/2008 | US20080306262 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 12/11/2008 | US20080306258 Cyclopropane compounds and pharmaceutical use thereof |
| 12/11/2008 | US20080306099 Compositions and methods for inhibition of the jak pathway |
| 12/11/2008 | US20080306098 Pharmacokinetics of protease inhibitors and other drugs |
| 12/11/2008 | US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306053 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306051 HIV Integrase Inhibitors |
| 12/11/2008 | US20080303433 Fluorene-based derivative and organic electroluminescence device employing the same |
| 12/11/2008 | DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound |